MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression.
- Resource Type
- Article
- Source
- Biomarker Research; 6/17/2022, Vol. 10 Issue 1, p1-17, 17p
- Subject
BIOMARKERS GLIOMA treatment SUPRATENTORIAL brain tumors TUMORS in children CANCER invasiveness INDIVIDUALIZED medicine - Language
- ISSN
- 20507771